Final Results

AI SummaryClose X

Surgical Innovations Group PLC reported final results for the year ended 31 December 2025, with revenues broadly flat at £11.6 million compared to £11.9 million in 2024. While SI Branded products saw an 8% decrease to £5.9 million due to tariff headwinds in the USA and sales challenges in India, Europe demonstrated strong growth of 23% to £2.1 million, and UK distribution revenues increased by 14% to £4.1 million. The company experienced an adjusted EBITDA loss of £0.4 million, an improvement from a £0.05 million profit in 2024, and a net cash inflow from operations of £0.6 million. Underlying gross margins increased to 33.73% from 30.65%, driven by a shift towards Elemental products. The company is focused on cost-down initiatives and operational efficiencies to drive further margin improvement and profitability in 2026, with a positive start to Q1 trading.

Disclaimer*

UK 100

Latest directors dealings